Drugs / DA-1229_01-R
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT07297940 | Dec 2025 → Jan 2026 | — | Dong-A ST Co., Ltd. | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT07342062 Comparator | Jan → Feb 2026 | — | Dong-A ST Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DA-1229_01-R | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07297940 ↗ |